Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Advocacy and Why It’s For You – #XchangeSA

Mar 10, 2020/Podcast

APTA’s live #XchangeSA chat with Kendra Lucas, PT, DPT on advocacy.

APTA Societal Impact Award

Awards

This award recognizes and rewards an association member who demonstrates leadership, commitment and dedication to addressing issues related to societal welfare.

Establishment and Review of an APTA National Award

Feb 20, 2026/Policies & Bylaws

House Policy: Describes the process for establishing an APTA National Award.

QuickDASH

May 25, 2017/Test & Measure

This is a measure of disability and symptoms in patients with musculoskeletal disorders that is region specific to the upper limb.

APTA Offers Insights on the Strategic Implementation of AI in Health Care to HHS

Mar 18, 2026/Article

In February, APTA submitted comments to the U.S. Department of Health and Human Services in response to their Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care. In its comments, APTA acknowledged the growing and transformative role AI can play

Defining Moment: You Did It

Feb 1, 2024/Column

A special White Coat Ceremony reminds a PT of the lasting impact of her physical therapy career and her commitment as a mother.

APTA 100 Days of Service Member Profile: Reed Handlery, PT, DPT, PhD

Oct 27, 2021/Open Access

"The challenge combines what we do best: movement and service to others. Since 2020 the challenge has supported DEI efforts."

And the Beat Goes On: APTA's Commercial Payer Advocacy

Apr 21, 2021/Roundup

Lots of payers with multiple plans mean the conversation never stops. Here are a few advocacy efforts that APTA is pursuing.

Shaping Our Next 100 Years: Creating a Tool for Change

Feb 23, 2021/Perspective

We can engage now, not at some point in the future.

Study: Excessive Sitting Time Is a Global Problem

Jul 6, 2022/Review

Researchers say sedentary lifestyles are increasing death and CVD rates worldwide — and that lower-income countries may be at greater risk.